Literature DB >> 22298395

Impairment of performance associated with long-term use of benzodiazepines.

C Gorenstein1, M A Bernik, S Pompéia, T Marcourakis.   

Abstract

The long-term effects of benzodiazepines (BDZ) on psychomotor and cognitive functions were assessed in 28 out patients, users of low therapeutic doses of diazepam (13.6 ± 4.9 mg/day, range: 5-20 mg/day) for 5-20 years (10.1 ± 5.0 years). These patients' performance was compared with two control groups: 53 BDZ-free anxious out patients and 56 healthy volunteers. The three groups were similar in sex, age and education. BDZ chronic users were tested before and after short-term (3 weeks) and long-term discontinuation (at an average of 10 months). Performance of chronic users of BDZ was consistently worse than those of the control groups, suggesting an impairment in these patients on both psychomotor and cognitive functions. These were not related to either dose or cumulative exposure to BDZ, and were also independent of diagnosis and levels of anxiety and depression. Moreover, these deficits were persistent as their performance failed to improve after drug discontinuation.

Entities:  

Year:  1995        PMID: 22298395     DOI: 10.1177/026988119500900404

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  Impairment of contrast sensitivity in long-term lorazepam users.

Authors:  Anne Giersch; Claude Speeg-Schatz; Monique Tondre; Sylvaine Gottenkiene
Journal:  Psychopharmacology (Berl)       Date:  2006-04-04       Impact factor: 4.530

2.  Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort.

Authors:  Olivia Boeuf-Cazou; Bienvenu Bongue; David Ansiau; Jean-Claude Marquié; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2011-04-15       Impact factor: 2.953

3.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

4.  Benzodiazepine use in Sao Paulo, Brazil.

Authors:  Angela Maria Campanha; Beatriz Ravagnani; Igor André Milhorança; Márcio Antonini Bernik; Maria Carmen Viana; Yuan-Pang Wang; Laura Helena Andrade
Journal:  Clinics (Sao Paulo)       Date:  2020-07-10       Impact factor: 2.365

5.  Cognitive effects of long-term benzodiazepine use: a meta-analysis.

Authors:  Melinda J Barker; Kenneth M Greenwood; Martin Jackson; Simon F Crowe
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

7.  Benzodiazepines and semantic memory: effects of lorazepam on the Moses illusion.

Authors:  Marie Izaute; Laurence Paire-Ficout; Elisabeth Bacon
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

8.  Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study.

Authors:  Pin-Liang Chen; Wei-Ju Lee; Wei-Zen Sun; Yen-Jen Oyang; Jong-Ling Fuh
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 9.  Mexazolam: clinical efficacy and tolerability in the treatment of anxiety.

Authors:  Hélder Fernandes; Ricardo Moreira
Journal:  Neurol Ther       Date:  2014-03-29

Review 10.  Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic Review.

Authors:  Danilo Nader; Linda Gowing
Journal:  J Addict       Date:  2020-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.